Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Radiodermatitis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global radiodermatitis market reached a value of US$ 464.4 Million in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 579.5 Million by 2027, exhibiting a growth rate (CAGR) of 3.60% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Radiodermatitis, or radiation dermatitis, refers to a skin condition caused due to radiation therapy used for the treatment of cancer. It generally occurs as a side effect during cancer treatment or after interventional radiology in patients with cancers of the breast, lungs, skin, neck, head or perineum region where the skin is part of the target field. Some of the commonly used products to treat radiodermatitis include topical antibiotics, corticosteroids, hydrophilic creams, hydrogel and hydrocolloid dressings, silicone-coated dressings, silver-leaf dressings, oral analgesics, and anti-inflammatory agents. In recent years, radiodermatitis treatment has gained traction as it helps reduce discomfort, minimize pain and prevent interruption in ongoing therapy while improving the overall quality of the patient’s life. 

 

 
 

www.imarcgroup.com

Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

Radiodermatitis Market Trends:

The widespread prevalence of cancer and the rising adoption of radiation therapy as a treatment option represent the primary factors driving the market growth. Besides this, the increasing geriatric population across the globe and the growing need to counter the adverse side effects of radiation therapy are augmenting the demand for radiodermatitis treatment. Additionally, numerous governing and non-governing agencies are taking favorable initiatives to spread awareness regarding the available radiodermatitis treatment and management products. This, in confluence with the rising public and private investments in the ongoing research and development (R&D) activities in the field of life sciences, is catalyzing the market growth. Furthermore, the leading players are focusing on developing innovative product variants to expand their product portfolio and gain a competitive edge. Moreover, the rising number of clinical trials, favorable government policies, increasing consumer expenditure capacities, improving healthcare infrastructure and easy availability of generic drugs are some of the other factors creating a positive market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global radiodermatitis market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product and distribution channel.

Breakup by Product:

 

 
 

www.imarcgroup.com

Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • Topical
    • Corticosteroids
    • Hydrophilic Creams
    • Antibiotics
    • Others
  • Oral
  • Dressings
    • Hydrogel and Hydrocolloid Dressings
    • No Sting Barrier Film
    • Honey Impregnated Gauze
    • Silicone Coated Dressings
    • Others
       

Breakup by Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
     

Breakup by Region:

 

 
 

www.imarcgroup.com

To get more information on the regional analysis of this market, Request Sample

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Bausch Health Companies Inc., Bayer AG, BMG PHARMA S.p.A., Charles River Laboratories International Inc., ConvaTec Group plc, Helsinn Healthcare SA, ICON plc, Integra LifeSciences, Mölnlycke Health Care AB and Stratpharma AG.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Million
Segment Coverage Product, Distribution Channel, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered 3M Company, Bausch Health Companies Inc., Bayer AG, BMG PHARMA S.p.A., Charles River Laboratories International Inc., ConvaTec Group plc, Helsinn Healthcare SA, ICON plc, Integra LifeSciences, Mölnlycke Health Care AB and Stratpharma AG.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1    Preface
2    Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction
    4.1    Overview
    4.2    Key Industry Trends
5    Global Radiodermatitis Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product
    6.1    Topical
        6.1.1 Market Trends
        6.1.2 Key Segments
           6.1.2.1 Corticosteroids
           6.1.2.2 Hydrophilic Creams
           6.1.2.3 Antibiotics
           6.1.2.4 Others
        6.1.3 Market Forecast
    6.2    Oral
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Dressings
        6.3.1 Market Trends
        6.3.2 Key Segments
           6.3.2.1 Hydrogel and Hydrocolloid Dressings
           6.3.2.2 No Sting Barrier Film
           6.3.2.3 Honey Impregnated Gauze
           6.3.2.4 Silicone Coated Dressings
           6.3.2.5 Others
        6.3.3 Market Forecast
7    Market Breakup by Distribution Channel
    7.1    Hospital Pharmacy
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Retail Pharmacy
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Online Pharmacy
        7.3.1 Market Trends
        7.3.2 Market Forecast
8    Market Breakup by Region
    8.1    North America
        8.1.1 United States
           8.1.1.1 Market Trends
           8.1.1.2 Market Forecast
        8.1.2 Canada
           8.1.2.1 Market Trends
           8.1.2.2 Market Forecast
    8.2    Asia-Pacific
        8.2.1 China
           8.2.1.1 Market Trends
           8.2.1.2 Market Forecast
        8.2.2 Japan
           8.2.2.1 Market Trends
           8.2.2.2 Market Forecast
        8.2.3 India
           8.2.3.1 Market Trends
           8.2.3.2 Market Forecast
        8.2.4 South Korea
           8.2.4.1 Market Trends
           8.2.4.2 Market Forecast
        8.2.5 Australia
           8.2.5.1 Market Trends
           8.2.5.2 Market Forecast
        8.2.6 Indonesia
           8.2.6.1 Market Trends
           8.2.6.2 Market Forecast
        8.2.7 Others
           8.2.7.1 Market Trends
           8.2.7.2 Market Forecast
    8.3    Europe
        8.3.1 Germany
           8.3.1.1 Market Trends
           8.3.1.2 Market Forecast
        8.3.2 France
           8.3.2.1 Market Trends
           8.3.2.2 Market Forecast
        8.3.3 United Kingdom
           8.3.3.1 Market Trends
           8.3.3.2 Market Forecast
        8.3.4 Italy
           8.3.4.1 Market Trends
           8.3.4.2 Market Forecast
        8.3.5 Spain
           8.3.5.1 Market Trends
           8.3.5.2 Market Forecast
        8.3.6 Russia
           8.3.6.1 Market Trends
           8.3.6.2 Market Forecast
        8.3.7 Others
           8.3.7.1 Market Trends
           8.3.7.2 Market Forecast
    8.4    Latin America
        8.4.1 Brazil
           8.4.1.1 Market Trends
           8.4.1.2 Market Forecast
        8.4.2 Mexico
           8.4.2.1 Market Trends
           8.4.2.2 Market Forecast
        8.4.3 Others
           8.4.3.1 Market Trends
           8.4.3.2 Market Forecast
    8.5    Middle East and Africa
        8.5.1 Market Trends
        8.5.2 Market Breakup by Country
        8.5.3 Market Forecast
9    SWOT Analysis
    9.1    Overview
    9.2    Strengths
    9.3    Weaknesses
    9.4    Opportunities
    9.5    Threats
10    Value Chain Analysis
11    Porters Five Forces Analysis
    11.1    Overview
    11.2    Bargaining Power of Buyers
    11.3    Bargaining Power of Suppliers
    11.4    Degree of Competition
    11.5    Threat of New Entrants
    11.6    Threat of Substitutes
12    Price Analysis
13    Competitive Landscape
    13.1    Market Structure
    13.2    Key Players
    13.3    Profiles of Key Players
        13.3.1    3M Company
           13.3.1.1 Company Overview
           13.3.1.2 Product Portfolio
           13.3.1.3 Financials
           13.3.1.4 SWOT Analysis
        13.3.2    Bausch Health Companies Inc.
           13.3.2.1 Company Overview
           13.3.2.2 Product Portfolio
           13.3.2.3 Financials
           13.3.2.4 SWOT Analysis
        13.3.3    Bayer AG
           13.3.3.1 Company Overview
           13.3.3.2 Product Portfolio
           13.3.3.3 Financials
           13.3.3.4 SWOT Analysis
        13.3.4    BMG PHARMA S.p.A.
           13.3.4.1 Company Overview
           13.3.4.2 Product Portfolio
        13.3.5    Charles River Laboratories International Inc.
           13.3.5.1 Company Overview
           13.3.5.2 Product Portfolio
           13.3.5.3 Financials
           13.3.5.4 SWOT Analysis
        13.3.6    ConvaTec Group plc
           13.3.6.1 Company Overview
           13.3.6.2 Product Portfolio
           13.3.6.3 Financials
        13.3.7    Helsinn Healthcare SA
           13.3.7.1 Company Overview
           13.3.7.2 Product Portfolio
        13.3.8    ICON plc
           13.3.8.1 Company Overview
           13.3.8.2 Product Portfolio
           13.3.8.3 Financials
           13.3.8.4 SWOT Analysis
        13.3.9    Integra LifeSciences
           13.3.9.1 Company Overview
           13.3.9.2 Product Portfolio
           13.3.9.3 Financials
           13.3.9.4 SWOT Analysis
        13.3.10    Mölnlycke Health Care AB
           13.3.10.1 Company Overview
           13.3.10.2 Product Portfolio
           13.3.10.3 SWOT Analysis
        13.3.11    Stratpharma AG
           13.3.11.1 Company Overview
           13.3.11.2 Product Portfolio

List of Figures

Figure 1: Global: Radiodermatitis Market: Major Drivers and Challenges
Figure 2: Global: Radiodermatitis Market: Sales Value (in Million US$), 2016-2021
Figure 3: Global: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 4: Global: Radiodermatitis Market: Breakup by Product (in %), 2021
Figure 5: Global: Radiodermatitis Market: Breakup by Distribution Channel (in %), 2021
Figure 6: Global: Radiodermatitis Market: Breakup by Region (in %), 2021
Figure 7: Global: Radiodermatitis (Topical) Market: Sales Value (in Million US$), 2016 & 2021
Figure 8: Global: Radiodermatitis (Topical) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 9: Global: Radiodermatitis (Oral) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Radiodermatitis (Oral) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Radiodermatitis (Dressings) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Radiodermatitis (Dressings) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Radiodermatitis (Hospital Pharmacy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Radiodermatitis (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Radiodermatitis (Retail Pharmacy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Radiodermatitis (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Radiodermatitis (Online Pharmacy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Radiodermatitis (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: North America: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: North America: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: United States: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: United States: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Canada: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Canada: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Asia-Pacific: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Asia-Pacific: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: China: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: China: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Japan: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Japan: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: India: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: India: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: South Korea: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: South Korea: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Australia: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Australia: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Indonesia: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Indonesia: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Others: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Others: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Europe: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Europe: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Germany: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Germany: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: France: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: France: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: United Kingdom: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: United Kingdom: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Italy: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Italy: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Spain: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Spain: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Russia: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Russia: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Others: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Others: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Latin America: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Latin America: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Brazil: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Brazil: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Mexico: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Mexico: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Others: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Others: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Middle East and Africa: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Middle East and Africa: Radiodermatitis Market: Breakup by Country (in %), 2021
Figure 67: Middle East and Africa: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Global: Radiodermatitis Industry: SWOT Analysis
Figure 69: Global: Radiodermatitis Industry: Value Chain Analysis
Figure 70: Global: Radiodermatitis Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Radiodermatitis Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Radiodermatitis Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Radiodermatitis Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 4: Global: Radiodermatitis Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 5: Global: Radiodermatitis Market: Competitive Structure
Table 6: Global: Radiodermatitis Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

The global radiodermatitis market was valued at US$ 464.4 Million in 2021.

We expect the global radiodermatitis market to exhibit a CAGR of 3.60% during 2022-2027.

The sudden outbreak of the COVID-19 pandemic had led to postponement of elective radiodermatitis treatments to reduce the risk of the coronavirus infection upon hospital visits or interaction with healthcare professionals.

 

The rising demand for radiodermatitis treatment to reduce discomfort, minimize pain, and prevent interruption in ongoing radiation therapy, which is used to treat cancer, is primarily driving the global radiodermatitis market.

Based on the product, the global radiodermatitis market has been segmented into topical, oral, and dressings. Currently, topical holds the majority of the total market share.

Based on the distribution channel, the global radiodermatitis market can be divided into hospital pharmacy, retail pharmacy, and online pharmacy. Among these, retail pharmacy exhibits a clear dominance in the market.

On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where Asia-Pacific currently dominates the global market.

Some of the major players in the global radiodermatitis market include 3M Company, Bausch Health Companies Inc., Bayer AG, BMG PHARMA S.p.A., Charles River Laboratories International Inc., ConvaTec Group plc, Helsinn Healthcare SA, ICON plc, Integra LifeSciences, Mölnlycke Health Care AB, and Stratpharma AG.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Related Report

Pregnancy Detection Kits Market by Product (Home Pregnancy Tests (HPT), Digital Devices, and Others), Test Type (Urine Test for HCG, Blood Test for HCG, and Others), End User (Household, Gynecology Clinics, Hospitals), and Region 2023-2028

Read More

Fabry Disease Market by Type (Type 1, Type 2, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Homecare, Specialty Clinics, and Others), and Region 2023-2028

Read More

Urinary Retention Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033

Read More

Atopic Dermatitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033

Read More

Swine Healthcare Market by Product (Diagnostic Tests, Therapeutics), Disease (Exudative Dermatitis, Coccidiosis, Respiratory Diseases, Swine Dysentery, Porcine Parvovirus, and Others), Route of Administration (Injectable, Oral), Distribution Channel (Veterinary Hospitals, Retail Pharmacy, Online Pharmacy), and Region 2023-2028

Read More

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )

Drop us an email at

sales@imarcgroup.com

Social Links

4